DEFA14A: Flaherty & Crumrine Funds Annual Meeting Adjourned, Shareholders Urged to Vote on Key Proposals

The Annual Meeting of Shareholders for Flaherty & Crumrine Funds has been adjourned to April 25th, 2025, due to low shareholder participation, with shareholders being asked to vote on electing directors and approving a new investment advisory agreement.

Summary

• The Annual Meeting of Shareholders for Flaherty & Crumrine Preferred and Income Securities Fund, along with other related funds, has been adjourned from April 16th to April 25th, 2025, due to insufficient shareholder participation.
• Shareholders are being asked to vote on two key proposals: electing directors for each fund and approving a new investment advisory agreement with Flaherty & Crumrine Incorporated.
• The new investment advisory agreement maintains the existing investment advisory fees, investment objectives, principal investment strategies, and day-to-day fund management.
• The primary reason for the new agreement is an internal restructuring within Flaherty & Crumrine involving the repurchase of shares from retired shareholders and reallocation to management shareholders, potentially triggering a change of control.
• The restructuring is expected to occur in stages between July 1 and December 31, 2025.
• Approval of the new agreement is necessary for Flaherty & Crumrine to continue providing investment advisory services to the funds.
• Shareholders are urged to submit their votes promptly, and assistance is available through Okapi Partners LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a delay in the annual meeting, the core operations and fees remain unchanged, and the board recommends approval. The restructuring is presented as a necessary administrative step.

Positives

• The new investment advisory agreement maintains the existing investment advisory fees.
• There are no changes to the investment objective and principal investment strategies.
• The day-to-day management of the fund remains the same.

Negatives

• The Annual Meeting had to be adjourned due to a lack of shareholder participation, indicating potential apathy or lack of awareness among shareholders.

Risks

• Failure to approve the new investment advisory agreement could disrupt the funds' management and operations.
• The internal restructuring at Flaherty & Crumrine could introduce uncertainty, although the document states no changes are expected in day-to-day management.

Future Outlook

The document indicates that the internal restructuring at Flaherty & Crumrine is expected to occur between July 1 and December 31, 2025, and the new investment advisory agreement needs to be approved for the company to continue providing services to the funds.

Management Comments

• The Board of Directors unanimously recommends that shareholders vote FOR the proposals.

Industry Context

Investment advisory agreements are standard in the fund management industry, and changes often trigger shareholder votes to ensure continuity and alignment of interests. Internal restructurings and potential changes of control are also common events that require careful management and communication with stakeholders.

Comparison to Industry Standards

• It's common for investment firms to undergo internal restructurings, such as the one described for Flaherty & Crumrine.
• Similar firms like BlackRock or PIMCO also have advisory agreements that are subject to shareholder approval upon material changes.
• The fact that the advisory fees remain unchanged is a positive sign, as fee increases are often met with shareholder resistance.

Stakeholder Impact

• Shareholders are directly impacted by the proposed changes and are being asked to vote on them.
• Employees of Flaherty & Crumrine are indirectly impacted by the internal restructuring.
• The funds' clients are indirectly impacted as the investment advisory agreement ensures continuity of services.

Next Steps

• Shareholders need to vote on the proposals.
• Flaherty & Crumrine will proceed with its internal restructuring between July 1 and December 31, 2025, contingent on shareholder approval of the new advisory agreement.

Key Dates

Keywords

Flaherty & Crumrine, Annual Meeting, Shareholders, Investment Advisory Agreement, Proxy Vote, Fund Restructuring, Change of Control